PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Uncovering new functions of a gene implicated in cancer growth opens new therapeutic possibilities

2015-04-29
(Press-News.org) Weill Cornell Medical College researchers have shown for the first time that a gene previously implicated in blood vessel formation during embryonic development and tumor growth also induces immune suppression during tumor development. This finding, published April 29 in Nature Communications, opens the door for new therapeutic approaches and vaccine development in treating patients with melanoma and other advanced-staged cancers.

Two decades ago, researchers discovered that a gene called Inhibitor of Differentiation 1 (Id1), which is normally found in the embryo, was also present in cancer patients and contributing to tumor progression. The present study reveals another way that Id1 works, hijacking a normal pathway in immune cell development and interfering with the entire immune system, starting in the bone marrow. Without competent immune cells, the body can't fight off tumors, and instead, cancer is allowed to grow, spread and thrive.

"Targeting Id1 offers the potential to restore overall immune function," said senior author Dr. David Lyden, the Stavros S. Niarchos Professor in Pediatric Cardiology and a professor of pediatrics in the Department of Pediatrics at Weill Cornell Medical College. "When the immune system is functioning, treatment options are more plentiful. Given the increased incidence and death rates tied to advanced stage metastatic cancers, there is also an increased urgency to understand how pro-metastatic, immunosuppressive mechanisms, like those driven by Id1, work."

The investigators discovered that a tumor-secreted protein called transforming growth factor beta (TGFβ) promotes the activation of Id1. The gene then sets off a chain reaction that redirects immune cells down a new pathway that churns out immature suppressor cells, extinguishing the immune system's ability to mount an effective defense and allowing cancer to grow and spread unabated.

"Normally, the bone marrow produces, among other immune cell types, dendritic cells, which are capable of stopping the spread and growth of tumors," said first author Dr. Marianna Papaspyridonos, who was a Fulbright Cancer Research Fellow at Cornell University in Dr. Lyden's lab. "But when TGFβ is released by the tumor and Id1 is upregulated, the normal generation of dendritic cells is interrupted, and instead another subset of immune cells, which suppresses the immune system, is formed."

Those immune cells, called myeloid-derived suppressor cells, allow cancer to more readily grow and spread. The researchers validated this finding in advanced melanoma patients, who have increased TGFβ plasma levels and higher levels of Id1 in myeloid peripheral blood cells.

Targeting Id1 might provide a three-pronged therapeutic approach, which would first reduce the metastatic potential of the tumor itself, then reduce the tumor's ability to form new blood vessels, a process called vasculogenesis, and finally restore the patient's systemic immune function.

"With this approach, immune cells will recognize a tumor as foreign and attack it," said Dr. Lyden, who also has appointments in the Sandra and Edward Meyer Cancer Center and the Gale and Ira Drukier Institute for Children's Health at Weill Cornell Medical College. "This will improve vaccine development, lead to better treatment outcomes and ultimately benefit cancer patients."

INFORMATION:

Weill Cornell Medical College

Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, the Medical College is the first in the U.S. to offer its M.D. degree overseas. Weill Cornell is the birthplace of many medical advances -- including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson's disease, and most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with Houston Methodist. For more information, visit END



ELSE PRESS RELEASES FROM THIS DATE:

Combined chemotherapy and immunotherapy shows promise for advanced prostate cancers

2015-04-29
Chemotherapy can be very effective against small prostate tumors. Larger prostate tumors, however, accumulate cells that suppress the body's immune response, allowing the cancer to grow despite treatment. Researchers at the University of California, San Diego School of Medicine now find that blocking or removing these immune-suppressing cells allows a special type of chemotherapy -- and the immune cells it activates -- to destroy prostate tumors. This novel combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate ...

Researchers find 200-year lag between climate events in Greenland, Antarctica

Researchers find 200-year lag between climate events in Greenland, Antarctica
2015-04-29
CORVALLIS, Ore. - A new study using evidence from a highly detailed ice core from West Antarctica shows a consistent link between abrupt temperature changes on Greenland and Antarctica during the last ice age, giving scientists a clearer picture of the link between climate in the northern and southern hemispheres. Greenland climate during the last ice age was very unstable, the researchers say, characterized by a number of large, abrupt changes in mean annual temperature that each occurred within several decades. These so-called "Dansgaard-Oeschger events" took place ...

In online movie marketing, less is more

2015-04-29
Video didn't killed the radio star, as the eponymous 1978 pop song predicted, and now, researchers have found, cross-channel discounts for online movie sales don't cannibalize online rentals of the same movie. Analyzing data from a major movie studio that distributes its catalog of titles online, Jing Gong, a doctoral candidate in information systems and management at Carnegie Mellon University, and her co-authors measured the impact of price discounts on own- and cross-channel sales of digital movies. They confirmed their expectation that digital movie consumers are ...

Five-year survivors of esophageal cancer still face low but constant risks

2015-04-29
Seattle, WA, April 29, 2015 - Patients with esophageal cancer who survive 5 years after undergoing surgery might breathe a sigh of relief and become complacent about continued monitoring. In fact, there is little published information on the outcome of patients with locally advanced esophageal cancer (LAEC) who survive beyond the 5-year mark. A study that will be presented by Brendon Stiles, MD, Associate Professor of Cardiothoracic Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, at the 95th AATS Annual Meeting finds that these survivors still face ...

Danish discovery may change cancer treatment

2015-04-29
Danish researchers from the University of Copenhagen and Herlev Hospital have made a discovery that may change the principles for treating certain types of cancer. The discovery relates to the so-called telomeres that constitute the ends of human chromosomes. Short telomeres are related to unhealthy lifestyles, old age and the male gender - all of which are risk factors in terms of high mortality. Up until now, the assumption has been that short telomeres are related to ill health. The challenge for researchers worldwide has therefore been to find out whether or not the ...

Bone marrow cell transplants used to treat fractures, lung injury, and renal obstruction

2015-04-29
Putnam Valley, NY. (April 28, 2015) - Mesenchymal stem cells (MSCs) have been transplanted to successfully treat a variety of diseases and conditions. The benefit of using MSCs is their ability to self-renew and differentiate into a variety of specialized cell types, such as osteoblasts (cells contributing to bone formation), chondrocytes (cartilage cells), adipocytes (fat cells), myocardiocytes (the muscle cells that make up the cardiac muscle), and neurons (nervous system cells). MSCs have shown the ability to modulate the immune response and therefore reduce local ...

Why do obese men get bariatric surgery far less than women?

2015-04-29
A new study by researchers at the University of California, San Diego School of Medicine has identified demographic, socioeconomic and cultural factors that contribute to a major gender disparity among U.S. men and women undergoing weight loss surgeries. Men undergo the surgeries in far lower numbers than women. The study is published in the March issue of the Journal of Laparoendoscopic & Advanced Surgical Techniques. Eighty percent of patients who undergo bariatric surgery, which involve procedures that either limit the amount of food that can be consumed or reduce ...

Consumption rises with automated bill payment

2015-04-29
DURHAM, N.C. -- The adage "out of sight, out of mind" applies to electricity use, according to new research from Duke University's Sanford School of Public Policy. A study of 16 years of billing records from one South Carolina utility found that residential customers using automatic bill payments consumed 4 to 6 percent more power than those who did not. Commercial electricity customers used 8 percent more. And low-income residents who enrolled in budget billing to spread the cost of seasonal peak demand across the year used 7 percent more electricity. "It's a perverse ...

Researchers closer to being able to change blood types

2015-04-29
What do you do when a patient needs a blood transfusion but you don't have their blood type in the blood bank? It's a problem that scientists have been trying to solve for years but haven't been able to find an economic solution - until now. University of British Columbia chemists and scientists in the Centre for Blood Research have created an enzyme that could potentially solve this problem. The enzyme works by snipping off the sugars, also known as antigens, found in Type A and Type B blood, making it more like Type O. Type O blood is known as the universal donor and ...

Research seeks alternatives for reducing bacteria in fresh produce using nanoengineering

2015-04-29
DETROIT - Nearly half of foodborne illnesses in the U.S. from 1998 through 2008 have been attributed to contaminated fresh produce. Prevention and control of bacterial contamination on fresh produce is critical to ensure food safety. The current strategy remains industrial washing of the product in water containing chlorine. However, due to sanitizer ineffectiveness there is an urgent need to identify alternative antimicrobials, particularly those of natural origin, for the produce industry. A team of researchers at Wayne State University have been exploring natural, ...

LAST 30 PRESS RELEASES:

From camera to lab: Dr. Etienne Sibille transforms brain aging and depression research

Depression rates in LGBTQIA+ students are three times higher than their peers, new research suggests

Most parents don’t ask about firearms in the homes their kids visit

Beer-only drinkers’ diets are worse than wine drinkers

Eco-friendly biomass pretreatment method yields efficient biofuels and adsorbents

How graph convolutions amplify popularity bias for recommendation?

New lignin-based hydrogel breakthrough for wound healing and controlled drug release

Enhancing compatibility and biodegradability of PLA/biomass composites via forest residue torrefaction

Time alone heightens ‘threat alert’ in teenagers – even when connecting on social media

Study challenges long-held theories on how migratory birds navigate 

Unlocking the secrets of ketosis

AI analysis of PET/CT images can predict side effects of immunotherapy in lung cancer

Making an impact. Research studies a new side of helmet safety: faceguard failures

Specific long term condition combinations have major role in NHS ‘winter pressures’

Men often struggle with transition to fatherhood amid lack of targeted information and support

More green space linked to fewer preventable deaths in most deprived areas of UK

Immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma

A formula for life? New model calculates chances of intelligent beings in our Universe and beyond

Could a genetic flaw be the key to stopping people craving sugary treats?

Experts urge complex systems approach to assess A.I. risks

Fossil fuel CO2 emissions increase again in 2024

Winners of Applied Microbiology International Horizon Awards 2024 announced

A toolkit for unraveling the links between intimate partner violence, trauma and substance misuse

Can everyday physical activity improve cognitive health in middle age?

Updated guidance reaffirms CPR with breaths essential for cardiac arrest following drowning

Study reveals medical boards rarely discipline physician misinformation

New treatment helps children with rare spinal condition regain ability to walk

'Grow Your Own' teacher prep pipeline at the University of Louisiana at Lafayette funded by US Department of Education

Lab-grown human immune system uncovers weakened response in cancer patients

More than 5 million Americans would be eligible for psychedelic therapy, study finds

[Press-News.org] Uncovering new functions of a gene implicated in cancer growth opens new therapeutic possibilities